Trophoblastic disease monitoring: Evaluation of pregnancy-specific β1-glycoprotein
- 1 October 1980
- journal article
- research article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 138 (3) , 313-320
- https://doi.org/10.1016/0002-9378(80)90255-0
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Pregnancy-Specific β-l-Glycoprotein in Trophoblastic Disease*Journal of Clinical Endocrinology & Metabolism, 1980
- Is SP1 (pregnancy specific β1 glycoprotein) elevated in cancer patients?International Journal of Cancer, 1979
- Human Chorionic Gonadotropin in the Plasma of Normal, Nonpregnant SubjectsNew England Journal of Medicine, 1979
- Pregnancy-Specific β1-Glycoprotein and Chorionic Gonadotropin-Like Immunoreactivity during the Latter Half of the Cycle in Women Using Intrauterine Contraception*Journal of Clinical Endocrinology & Metabolism, 1978
- Detection of trophoblastic tumour activity by pregnancy-specific beta-1-glycoproteinInternational Journal of Cancer, 1978
- PREGNANCY-SPECIFIC BETA-1-GLYCOPROTEIN LEVELS IN CHOLESTASIS OF PREGNANCY1978
- Trophoblast-Specific Beta1-Glycoprotein as a Marker for Pregnancy and MalignanciesGynecologic and Obstetric Investigation, 1978
- CONCENTRATIONS OF PREGNANCY-SPECIFIC β1-GLYCOPROTEIN IN MATERNAL BLOOD IN NORMAL PREGNANCY AND IN INTRAUTERINE GROWTH RETARDATIONThe Lancet, 1977
- Pregnancy specificβ 1 — a product of the syncytiotrophoblastCellular and Molecular Life Sciences, 1976
- A radioimmunoassay which specifically measures human chorionic gonadotropin in the presence of human luteinizing hormoneAmerican Journal of Obstetrics and Gynecology, 1972